Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor.

McKillop D, Partridge EA, Kemp JV, Spence MP, Kendrew J, Barnett S, Wood PG, Giles PB, Patterson AB, Bichat F, Guilbaud N, Stephens TC.

Mol Cancer Ther. 2005 Apr;4(4):641-9.

2.

VEGF directs newly gastrulated mesoderm to the endothelial lineage.

Giles PB, Candy CL, Fleming PA, Owens RW, Argraves WS, Drake CJ.

Dev Biol. 2005 Mar 1;279(1):169-78.

3.

Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers.

Martin PD, Warwick MJ, Dane AL, Hill SJ, Giles PB, Phillips PJ, Lenz E.

Clin Ther. 2003 Nov;25(11):2822-35.

PMID:
14693307

Supplemental Content

Loading ...
Support Center